Zacks Rating on Amedisys Inc (AMED)

Amedisys Inc (AMED) has an average broker rating of 2.11, which is interpreted as a Buy, as rated by 9 equity analysts. Nonetheless, 4 analysts are positive on the stocks future and they recommend a Strong Buy on the stock. Nevertheless, the majority of 5 analysts consider that the stock is a Hold with neither a large upside nor a downside. Ranking by Zacks Investment Research for Coach Inc is 3, which is also a Hold.

Amedisys Inc (AMED) : The highest short term price target forecast on Amedisys Inc (AMED) is $59 and the lowest target price is $48. A total of 7 equity analysts are currently covering the company. The average price of all the analysts is $54.71 with a standard deviation of $3.73.


Amedisys Inc. has lost 1.4% in the last five trading days and dropped 8.95% in the last 4 weeks. Amedisys Inc. has dropped 8.53% during the last 3-month period . Year-to-Date the stock performance stands at 21.62%. Amedisys Inc (NASDAQ:AMED): stock turned positive on Tuesday. Though the stock opened at $47.93, the bulls momentum made the stock top out at $48.06 level for the day. The stock recorded a low of $47.01 and closed the trading day at $47.82, in the green by 0.06%. The total traded volume for the day was 204,902. The stock had closed at $47.79 in the previous days trading.

Amedisys, Inc. (Amedisys) is a health care at home company. Amedisys delivers home health and hospice care to more than 360,000 patients each year. The Company has care network across 34 states. As of December 31, 2014, it owned and operated 316 Medicare-certified home health care centers and 80 Medicare-certified hospice care centers. The Company operates through two segments: home health and hospice. The Companys home health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with the essential activities of daily living. The Companys hospice segment provides palliative care and comfort to terminally ill patients and their families.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.